Pharmacokinetics of oral valganciclovir and intravenous ganciclovir administered to prevent cytomegalovirus disease in an adult patient receiving small-intestine transplantation

被引：12
作者：
Abete, JF
Martín-Dávila, P
Quijano, Y
de Vicente, E
Pon, L
机构：
[1] Hosp Ramon y Cajal, Dept Infect Dis, Liver & Intestinal Transplant Grp, Madrid 28034, Spain
[2] Hosp Ramon y Cajal, Dept Gen & Digest Surg, Liver & Intestinal Transplant Grp, Madrid 28034, Spain
[3] Hosp Gen Valle Hebron, Clin Lab, Pharmacol Unit, Barcelona, Spain
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2004年 / 48卷 / 07期
关键词：
D O I：
10.1128/AAC.48.7.2782-2783.2004
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：2782 / 2783
页数：2
相关论文
共 5 条
[1]   Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects [J].
Jung, D ;
Dorr, A .
JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (08) :800-804
[2]   HAMSTER-TO-RAT KIDNEY XENOTRANSPLANTATION - EFFECTS OF FK-506, CYCLOPHOSPHAMIDE, ORGAN PERFUSION, AND COMPLEMENT INHIBITION [J].
MIYAZAWA, H ;
MURASE, N ;
DEMETRIS, AJ ;
MATSUMOTO, K ;
NAKAMURA, K ;
YE, Q ;
MANEZ, R ;
TODO, S ;
STARZL, TE .
TRANSPLANTATION, 1995, 59 (08) :1183-1188
[3]   Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients [J].
Pescovitz, MD ;
Rabkin, J ;
Merion, RM ;
Paya, CV ;
Pirsch, J ;
Freeman, RB ;
O'Grady, J ;
Robinson, C ;
To, Z ;
Wren, K ;
Banken, L ;
Buhles, W ;
Brown, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (10) :2811-2815
[4]  
POU L, 1993, PERSPECTIVE BIOLOGY, P183
[5]  
REYES J, 1999, TXB CRITICAL CARE, P1678
1